NCT03226366

Brief Summary

Sepsis is a common syndrome resulting from a dysregulated response to infection. The timing of antibiotic initiation is an important determinant of outcomes for patients presenting to the emergency department with sepsis. The potential effect of care reorganization on very early care for sepsis is unknown. This study will investigate whether multidisciplinary coordination of the initial patient evaluation in the emergency department influences door-to-antibiotic time for septic patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,230

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2015

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 16, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 21, 2017

Completed
2.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 11, 2020

Completed
2 months until next milestone

Results Posted

Study results publicly available

June 18, 2020

Completed
Last Updated

June 18, 2020

Status Verified

June 1, 2020

Enrollment Period

1.7 years

First QC Date

July 19, 2017

Results QC Date

June 1, 2020

Last Update Submit

June 1, 2020

Conditions

Keywords

door-to-antibiotic timeemergency department careantimicrobialcare reorganizationsevere sepsisswarming

Outcome Measures

Primary Outcomes (1)

  • Time From ED Arrival to Administration of First Dose of Antibiotics

    24 hours

Secondary Outcomes (3)

  • Hospital Mortality

    Up to 1 year

  • ED Length of Stay

    Up to 1 week

  • Door-to-physician Evaluation Time

    Up to 24 hours

Study Arms (4)

Pre-implementation (intervention site)

Adult patients age ≥18 years who received usual care after presenting to the ED of the intervention hospital with sepsis or septic shock between May 16, 2015 and April 15, 2016

Post-implementation (intervention site)

Adult patients age ≥18 years eligible to receive immediate evaluation by multidisciplinary team ("swarming") after presenting to the ED of the intervention hospital with sepsis or septic shock between May 16, 2016 and February 15, 2017

Other: Immediate evaluation by multidisciplinary team

Pre-implementation (control site)

Adult patients age ≥18 years who received usual care after presenting to the ED of a non-intervention study hospital with sepsis or septic shock between May 16, 2015 and April 15, 2016

Post-implementation (control site)

Adult patients age ≥18 years who received usual care after presenting to the ED of a non-intervention study hospital with sepsis or septic shock between May 16, 2016 and February 15, 2017

Interventions

Simultaneous initial evaluation by the ED physician, nurse, and patient care associate

Also known as: Swarming
Post-implementation (intervention site)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients presenting to the ED with sepsis or septic shock

You may qualify if:

  • Adult patients age ≥18 years
  • Presented to the ED of study hospital from May 16, 2015 to April 15, 2016 (pre-implementation cohort) or May 16 to November 15, 2016 (post-implementation cohort)
  • Sepsis present in ED (Sequential Organ Failure Assessment \[SOFA\] score ≥2 points above baseline while in ED plus antibiotic initiation while in the ED)
  • Triage acuity score 2-5
  • Presented to the ED of study hospital between May 16, 2015 and April 15, 2016 (pre-implementation cohort) or May 16, 2016 and February 15, 2017 (post-implementation cohort).
  • Sepsis on presentation to ED, defined as initial Sequential Organ Failure Assessment (SOFA) score ≥2 points above baseline plus antibiotics initiation within 24 hours of ED arrival.

You may not qualify if:

  • Age \<18 years
  • No antibiotics within 24 hours of ED arrival

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Intermountain Medical Center

Murray, Utah, 84157, United States

Location

Riverton Hospital

Riverton, Utah, 84065, United States

Location

LDS Hospital

Salt Lake City, Utah, 84143, United States

Location

Alta View Hospital

Sandy City, Utah, 84094, United States

Location

Related Publications (1)

  • Peltan ID, Bledsoe JR, Brems D, McLean S, Murnin E, Brown SM. Institution of an emergency department "swarming" care model and sepsis door-to-antibiotic time: A quasi-experimental retrospective analysis. PLoS One. 2020 May 5;15(5):e0232794. doi: 10.1371/journal.pone.0232794. eCollection 2020.

MeSH Terms

Conditions

Shock, SepticSepsis

Interventions

RsbA protein, Proteus mirabilis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Results Point of Contact

Title
Director, Office of Research
Organization
Intermountain Healthcare

Study Officials

  • Ithan Peltan, MD, MSc

    Intermountain Health Care, Inc.

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Physician, Intermountain Medical Center

Study Record Dates

First Submitted

July 19, 2017

First Posted

July 21, 2017

Study Start

May 16, 2015

Primary Completion

January 31, 2017

Study Completion

April 11, 2020

Last Updated

June 18, 2020

Results First Posted

June 18, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will share

In order to protect patient privacy and comply with relevant regulations, identified data will be unavailable. Requests for deidentified data from qualified researchers with appropriate ethics board approvals and relevant data use agreements will be processed by the Intermountain Office of Research, officeofresearch@imail.org.

Shared Documents
STUDY PROTOCOL, CSR, ANALYTIC CODE

Locations